Sign In
Buy MRVI
$4.84
+0.0100 (+0.207%)
At Close: Jun 03, 2026
Maravai LifeSciences (NASDAQ:MRVI) Rating Increased to Buy at Zacks Investment Research
06:26am, Monday, 15'th Nov 2021 Dakota Financial News
Maravai LifeSciences (NASDAQ:MRVI) was upgraded by Zacks Investment Research from a hold rating to a buy rating in a report released on Saturday, Zacks.com reports. The firm presently has a $41.00 price target on the stock. Zacks Investment Researchs price target points to a potential upside of 9.01% from the companys previous close. According to []
Maravai LifeSciences Holdings, Inc. (MRVI) CEO Carl Hull on Q3 2021 Results - Earnings Call Transcript
08:32pm, Wednesday, 10'th Nov 2021
Maravai LifeSciences Holdings, Inc. (MRVI) CEO Carl Hull on Q3 2021 Results - Earnings Call Transcript
Maravai LifeSciences Announces November 2021 Investor Conference Schedule
08:30am, Tuesday, 02'nd Nov 2021
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to p
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 10, 2021
04:30pm, Wednesday, 13'th Oct 2021
SAN DIEGO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans t
New Strong Buy Stocks for October 8th
12:41pm, Friday, 08'th Oct 2021
CNXC, DLTH, NVEE, MRVI, and PFSI have been added to the Zacks Rank #1 (Strong Buy) List on October 8, 2021.
Maravai LifeSciences Expands its Intellectual Property Portfolio with European Patent
05:30am, Thursday, 07'th Oct 2021
Advancement Expected to Further Accelerate Development of mRNA Vaccines and Therapeutics Advancement Expected to Further Accelerate Development of mRNA Vaccines and Therapeutics
TriLink BioTechnologies® Extends EyeGene Partnership for COVID-19 Vaccine Development in South Korea
08:30am, Monday, 04'th Oct 2021
EyeGene expected to utilize TriLink's CleanCap® technology and modified UTP manufactured by TriLink in the production of its EG-COVID mRNA COVID-19 vaccine for clinical trials EyeGene expected to uti
3 High-Potential MedTech Stocks With More Than 50% Growth YTD
11:15am, Wednesday, 29'th Sep 2021
Stocks like West Pharmaceuticals Services (WST), Maravai LifeSciences (MRVI) and Option Care Health (OPCH) have gained stupendously year to date.
Why Maravai LifeSciences Tumbled Nearly 12% Today
06:34pm, Friday, 10'th Sep 2021
A private equity firm and several peers are cashing out of a pile of shares.
Maravai LifeSciences Announces Pricing of Secondary Offering of Class A Common Stock by Selling Stockholders
06:30am, Friday, 10'th Sep 2021
SAN DIEGO, Calif., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech i
Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders
04:10pm, Tuesday, 07'th Sep 2021
SAN DIEGO, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech i
Top Ranked Momentum Stocks to Buy for August 13th
11:38am, Friday, 13'th Aug 2021
MRVI, DSKE, VRTS, and RMBS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 13, 2021.
Maravai LifeSciences Holdings, Inc. (MRVI) CEO Carl Hull on Q2 2021 Results - Earnings Call Transcript
10:11pm, Tuesday, 10'th Aug 2021
Maravai LifeSciences Holdings, Inc. (MRVI) CEO Carl Hull on Q2 2021 Results - Earnings Call Transcript
TriLink enables Chula VRC to take its Covid-19 vaccine into a First in Human (FIH) phase 1 clinical trial in Thailand with mRNA manufacturing process development and its proprietary mRNA capping techn
Maravai LifeSciences To Host Earnings Conference Call on Tuesday, August 10, 2021
04:15pm, Tuesday, 20'th Jul 2021
SAN DIEGO, July 20, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans t
